SVTR 硅谷科技评论SVTR
← Database

VOINOSIS

VOINOSIS is a Seoul-based AI healthcare company founded in 2019 by otolaryngologist Shin Jung-eun.

Request an introWebsite ↗
ApplicationsLife Sciences
📍 Seoul · East AsiaFounded 2019

About

VOINOSIS is a Seoul-based AI healthcare company founded in 2019 by otolaryngologist Shin Jung-eun. It analyzes voice and hearing data to screen early for cognitive decline and dementia (including MCI and early Alzheimer's) and to manage age-related hearing loss, with products such as BrainGuard Doctor, VoiceCheck/Voice Wellness, HaHa Care and BrainGuard Therapy.

Founders / core team

Similar companies· Same sector “Life Sciences”

Cent

Life Sciences

Cent is a Bengaluru-based direct-to-consumer preventive healthcare company founded in 2025 by Practo co-founder Shashank ND, running clinical prevention centres that combine whole-body MRI, CT, DEXA and 100+ biomarkers with an in-house AI system that synthesises multimodal data into risk scores.

Tiny Health

Life Sciences

Tiny Health, founded in 2020 in Austin, Texas, started with infant gut health in the first 1,000 days and offers at-home gut and vaginal microbiome testing across the lifespan. Its TinyAI, trained on nearly 200,000 proprietary microbiome profiles, delivers personalized guidance tied to results; it serves nearly 200,000 customers and more than 6,000 healthcare practitioners.

Network Bio

Life Sciences

Network Bio is a Palo Alto, California biotechnology company founded in 2022 that builds disease-specific AI models from human biological data. Its vertically integrated platform combines a biological research network that sources, links and structures tissue, blood and longitudinal clinical outcomes from leading U.S. academic medical centers (Mass General Brigham, University of Pennsylvania, Duke University, University of Colorado Anschutz and UCSF, spanning 500,000+ patients across oncology, immunology, metabolic and cardiovascular disease) into AI-ready datasets, with a bio-native AI architecture purpose-built to learn from multimodal biological data, overcome technical confounders and batch effects, and generate interpretable representations of disease biology that generalize across diseases, tissues and modalities.

Lucis

Life Sciences

Lucis, founded in 2024 in Paris, France, helps consumers monitor metabolic health, hormone levels, cardiovascular risk, inflammation, and nutritional status based on blood biomarker analysis and AI-driven recommendations.

SuperDial

Life Sciences

SuperDial, founded in 2021 in San Francisco, USA, builds AI voice agents that handle insurance verification and billing follow-up calls for healthcare providers. The startup envisions a future where healthcare coordination is agent-powered—where payers, providers, pharmacies, labs, and other healthcare organizations can communicate with each other AI-to-AI.

Kraionyx AI

Life Sciences

Founded in 2025 in Hyderabad, India, Kraionyx AI builds high-assurance agentic AI systems for healthcare as "the intelligence layer" for clinicians: KareOS (clinical decision-support workspace with specialist medical agents), Svaani (ambient voice intelligence turning doctor-patient conversations into clinical documentation) and Doclave (a professional network for doctors to discuss cases).

Investors that may fit

InterVest

2 Life Sciences deals in the last 24 months · 1 in 东亚

Request intro →

General Catalyst

39 Life Sciences deals in the last 24 months

Request intro →

Y Combinator

38 Life Sciences deals in the last 24 months

Request intro →

Andreessen Horowitz

24 Life Sciences deals in the last 24 months

Request intro →

Khosla Ventures

20 Life Sciences deals in the last 24 months

Request intro →

Thrive Capital

18 Life Sciences deals in the last 24 months

Request intro →

Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.

Want to reach VOINOSIS — for capital, customers, or partnership? Send a short request; SVTR reviews it and brokers the intro, with both sides verified before you meet.

Request an intro to this companySubscribe to Signal